Advanced Filters
noise
Found 64,776 clinical trials
N Nicola Gallagher

Can the Use of Virtual Reality Improve TKA Outcomes

Virtual reality (VR) uses computer technology to create a three-dimensional environment which the user can explore and interact with. VR can be used to distract the patient during an operation and has been used to avoid sedative premedication, increase patient satisfaction and decrease pain during nerve blocks. VR used alongside …

18 - 100 years of age All Phase N/A

OM 85 to Prevent Respiratory Infections in Older At Risk Patients

People living in NH are at higher risk of respiratory infections compared to their counterpart living in the community. Products obtained from dead bacteria ("bacterial lysate") can be used to boost immune system and may reduce the risk of respiratory infections. Very little information is available on the effect of …

75 years of age All Phase 4
J Julie Lovegrove, Professor

The Impact of Faba Bean Rich Bread on Iron Status, Postprandial Lipaemia and Satiety

High levels of animal proteins (meat) in the diet are linked with a greater risk of developing heart disease and other long-term health conditions. Recently there has been a shift to plant-based diets including plant proteins such as pulses, defined as beans, peas, chickpeas and lentils. Pulses are a nutritious …

18 - 50 years of age All Phase N/A
A Andrea Scribante, Associate Professor

Lactoferrin-Based Oral Care for Periodontal Health in Pregnancy

This randomized controlled clinical trial aims to evaluate the effectiveness of a lactoferrin-based oral hygiene protocol in improving periodontal health during pregnancy. Forty pregnant women between the fourth and eighth month of gestation will be enrolled and randomly assigned to one of two groups. The trial group will undergo professional …

18 - 45 years of age Female Phase N/A

Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients

This is a 48-week randomized, open-label, parallel-controlled biosimilar comparison study comparing the efficacy, safety and immunogenicity of the investigational drug and WEGOVY® in patients with obesity. Eligible participants will be screened and randomized to the experimental group and the active comparator group at a ratio of 1:1 , semaglutide injection …

18 - 75 years of age All Phase 3
Y Yong Cao, M.D.

rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage

The purpose of this pilot study is to determine the safety and optimal dose of clot lysis with rhTNK-tPA for intraventricular hemorrhage, using stereotactic guidance for extraventricular drain placement.

18 - 80 years of age All Phase 1
Z Zhongcui Sun, PhD

hAM for Inferior RRD

The objective of the study is to evaluate the efficacy of using hAM patches over the retina to seal inferior retinal breaks. The researchers will evaluate whether hAM patch-assisted vitrectomy improves surgical success rate of retinal reattachment.

18 - 70 years of age All Phase N/A
H Haena Kim

Robot-Assisted Neurovascular Intervention

Patients scheduled for neurovascular interventions may be eligible to have their procedure done robotically.

18 - 80 years of age All Phase N/A
C Chinese PLA General Hospital

VIM+PTT MRgFUS for PD

The objective of this prospective, single-arm, open-label study is to assess the safety and efficacy of the staged, dual-target(VIM+PTT thalamotomy)to treat Patiensts with Parkinson Disease using transcranial magnetic resonance guided focused ultrasound system ExAblate 4000, InSightec Ltd.

22 years of age All Phase N/A
F Forca Mehmeti, M.Sc.

A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse

Prospective, multi-center, randomized, open label comparative Phase III study in patients with intermediate to high-risk (as defined in the SURVIVE trial) HER2-positive or HER2-low early breast cancer, who participate in the SURVIVE trial and experience a molecular relapse, as assessed based on a positive circulating tumor DNA (ctDNA) result, with …

18 - 75 years of age All Phase 3

Simplify language using AI